Why pre-screen technology transfer specialists before panel interviews with faculty inventors
Pre-screening technology transfer specialists protects your licensing committee and faculty panel from hours of wasted time. Applicants arrive from patent prosecution, postdoc benches, corporate business development, and other transfer offices, and a resume lists deals without saying whether they sourced the disclosure, drafted the term sheet, or simply docketed a file someone else closed. A ten minute screen shows whether they can price a licence, spot an inventor's overclaim, and explain a research result to a company that has to fund it.
What actually matters when screening Technology Transfer Specialist candidates
- 01
Record of outcomes
Check the deals they closed: licences, spin-outs, or partnerships, with terms and what the technology went on to do.
- 02
Strategic judgement
Test how they judge which inventions are worth patenting and pushing, and which to let go.
- 03
Building and leading teams
Assess how they work with inventors who overestimate their technology and industry partners who undervalue it.
- 04
Influence across the business
Judge how they translate a research result into a commercial case a company will fund.
Pre-screening questions to ask Technology Transfer Specialist candidates
11 questions grouped by what they test. Ask the same set in every screen and score answers on a consistent scale, or send them as an async video screen and compare answers side by side.
Deal track record
Walk us through one technology transfer project you've worked on, from invention disclosure to the agreement that closed.
A single named technology followed end to end: disclosure, filing decision, marketing effort, licensee type, deal structure, and what the technology did after signing.
They describe office processes in general terms and cannot say which parts of the deal they personally owned.
What experience do you have fostering partnerships with industry for technology transfer, and how did you get those companies to the table?
Concrete sourcing methods: conference targeting, outbound to named business development contacts, sponsored research that converted, or repeat licensees they built relationships with over years.
Partnerships arrived entirely through inbound enquiries or inventor contacts with no outbound effort of their own.
How do you deal with the financial aspects of technology transfer: valuation, royalty rates, milestones, and revenue sharing?
Real numbers and methods: comparable deal benchmarks, royalty ranges by sector, milestone triggers tied to clinical or product stages, and the institution's inventor share split.
They cannot quote a single royalty rate or milestone structure they have negotiated or defended.
Commercial judgement
How would you evaluate the commercial potential of a technology you have just seen for the first time?
A repeatable filter: patentability and prior art, technical readiness, market size and incumbents, remaining development cost, regulatory path, and whether an identifiable buyer exists.
They judge on novelty or publication quality alone, treating strong science as automatically licensable.
What market research and analysis have you carried out to support a tech transfer decision, and what did it change?
Named sources and an outcome: patent landscaping in Derwent or Espacenet, competitor product scans, analyst reports, or customer calls that redirected or killed a filing.
Research means a web search summarised into a slide with no decision attached to it.
Walk us through how a technology goes from lab to market, and where in product development you have personally been involved.
Accurate stage awareness: proof of concept, scale-up, regulatory or standards requirements, pilot deployment, and where translational funding or an SBIR type grant fits.
The path stops at the licence signature with no grasp of what the licensee still has to build.
IP and contracts
Detail your understanding of licensing and patent procedures, including what happens between a provisional filing and national phase entry.
Correct sequence and deadlines: provisional, PCT, twelve and thirty month decision points, office actions, and how filing spend is staged against licensee interest.
Confused or missing timelines, or an inability to distinguish exclusive, non-exclusive, and field-limited licences.
How comfortable are you drafting and negotiating legal contracts such as NDAs, MTAs, option agreements, and exclusive licences?
Specific clauses they have argued over: indemnity, diligence milestones, improvements, sublicensing, termination, and where they draw the line before escalating to counsel.
They only forward templates to legal and have never held a position in a negotiation themselves.
How do you manage the balance between confidentiality and necessary disclosure when marketing an unpatented invention?
A working practice: non-confidential summaries, staged disclosure under CDA, publication timing coordinated with filing dates, and inventor coaching before conference talks.
Casual attitude to enabling disclosure or public presentation before a priority filing exists.
Inventors and partners
Describe a time you had to make complex technical information understandable to non-technical stakeholders.
A named audience (corporate licensee, investor, committee) plus the specific reframing used: the problem solved, the customer, and the value, with the physics kept out.
They repeat the technical explanation more slowly rather than translating it into commercial terms.
What experience do you have coordinating with external technology transfer partners, such as outside patent counsel, other institutions' offices, or AUTM networks?
Practical detail on managing outside counsel budgets, inter-institutional agreements with a lead office, and shared prosecution or revenue splits on jointly owned inventions.
No experience with joint ownership or outside counsel, and no view on who leads a co-owned filing.
How to score responses
Score every candidate on the same four criteria immediately after the screen. At this stage you are shortlisting for panel interviews, not making the final call.
| Criterion | What a 5 looks like | Scale |
|---|---|---|
| Record of outcomes | Names licences or spin-outs they closed, with terms and what became of the technology afterwards. | 1 · 2 · 3 · 4 · 5 |
| Strategic judgement | Assesses commercial potential and freedom to operate realistically, and can name inventions they declined to back. | 1 · 2 · 3 · 4 · 5 |
| Building and leading teams | Manages inventor expectations and industry scepticism together, getting both to a term sheet they can live with. | 1 · 2 · 3 · 4 · 5 |
| Influence across the business | Translates research into a commercial case investors and licensees act on, without overstating readiness. | 1 · 2 · 3 · 4 · 5 |
Licensing lives or dies on how a specialist sounds pitching an early-stage invention to a sceptical company. Async video and audio prompts let you hear the pitch and the clarity of the technical explanation before anyone books a panel.
Try it on HirevireScreening FAQ
Process basics
What qualifications should a technology transfer specialist have?
Most offices expect a technical degree (often a PhD or MS in life sciences or engineering) plus hands-on licensing experience. Registered patent agent status or the USPTO bar is a plus, as is RTTP certification through ATTP. What matters more is a documented history of executed agreements: options, exclusive and non-exclusive licences, sponsored research deals, and spin-out equity.
How long should a pre-screen for this role take?
Ten to twelve minutes of recorded answers is enough. Use two or three short video or audio prompts for the judgement questions, such as evaluating commercial potential and explaining a technology to a non-technical stakeholder, and keep the rest as short text fields for patent procedure, contract types, and partner coordination experience.
Evaluating answers
How do you tell a real deal record from an inflated one?
Ask for terms, not titles. Strong candidates name the upfront fee range, royalty rate, milestone triggers, field of use, and diligence obligations, and they can say who the licensee was by type and what the technology went on to do. Vague references to "multi-million dollar deals" without structure usually mean they supported rather than led.
What separates good strategic judgement in patenting decisions?
Good judgement shows up in the inventions they declined. Listen for named criteria: breadth of claims achievable, enablement gaps, prior art found, market size, remaining development cost, and whether an industry partner was already interested before spending on national phase filings. Candidates who say they file on everything are describing a budget problem, not a strategy.
Go deeper on this role
Sanat has personally screened 300+ candidates across 18+ years of building and hiring teams, and turned that screening process into Hirevire's video screening platform. LinkedIn
